CLEC1B and neoplasm: The bidirectional signaling between platelet C-type lectin-like receptor 2 (CLEC-2) and podoplanin on tumor cells induces platelet activation, aggregation, and the secretion of bioactive molecules, thereby enhancing tumor cell survival [48].